Publications by authors named "Edward Matelan"

Claim this Profile
3
3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.
Robert R Singhaus, Ronald C Bernotas, Robert Steffan, Edward Matelan, Elaine Quinet

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
Jay Wrobel, Robert Steffan, S Marc Bowen, Ronald Magolda, Edward Matelan

J Med Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of chronic inflammation with pathway selective estrogen receptor ligands.
Robert J Steffan, Edward Matelan, Mark A Ashwell, William J Moore, William R Solvibile

Curr Top Med Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Christopher C Chadwick, Susan Chippari, Edward Matelan, Lisa Borges-Marcucci, Amy M Eckert

Proc Natl Acad Sci U S A· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
Robert J Steffan, Edward Matelan, Mark A Ashwell, William J Moore, William R Solvibile

J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 1: aryloxypropanolaminomethylpiperidines.
Robert J Steffan, Mark A Ashwell, William R Solvibile, Edward Matelan, Elwood Largis

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 2: arylethanolaminomethylpiperidines.
Robert J Steffan, Mark A Ashwell, William R Solvibile, Edward Matelan, Elwood Largis

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis